This inventor holds 3 USPTO granted patents. Top assignees: Astellas Pharma Gmbh, Other. Active years: 2001-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 424 
2 out of 834,513 Years Active: 2001-2006
Title: The Innovative Contributions of Masaya Sawamura
Introduction
Masaya Sawamura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of science, particularly in the area of DNA compaction through his innovative work with fullerene derivatives. With a total of 3 patents to his name, Sawamura's research has the potential to impact gene therapy and other applications.
Latest Patents
One of Sawamura's latest patents focuses on fullerene derivatives as a novel means for DNA compaction. This invention provides a fullerene derivative that contains 1 to 4 nitrogen-containing hydrophilic side chains or its salt, which effectively facilitates DNA compaction. The implications of this research extend to gene therapy, where effective DNA compaction can enhance therapeutic outcomes.
Career Highlights
Throughout his career, Masaya Sawamura has worked with various organizations, including Astellas Pharma GmbH. His work has been instrumental in advancing the understanding and application of fullerene derivatives in scientific research.
Collaborations
Masaya Sawamura has collaborated with notable scientists such as Eiichi Nakamura and Hiroyuki Isobe. These collaborations have enriched his research and contributed to the development of innovative solutions in his field.
Conclusion
Masaya Sawamura's contributions to the field of DNA compaction through his innovative patents highlight his role as a leading inventor. His work continues to pave the way for advancements in gene therapy and related applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile